Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ANTIHEMOPHILIC FACTOR HUMAN: 809 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
809
Total FAERS Reports
98 (12.1%)
Deaths Reported
200
Hospitalizations
809
As Primary/Secondary Suspect
24
Life-Threatening
9
Disabilities

First Report: 19790626 · Latest Report: 20250801

What Are the Most Common ANTIHEMOPHILIC FACTOR HUMAN Side Effects?

#1 Most Reported
Haemarthrosis
118 reports (14.6%)
#2 Most Reported
Haemorrhage
112 reports (13.8%)
#3 Most Reported
Drug ineffective
69 reports (8.5%)

All ANTIHEMOPHILIC FACTOR HUMAN Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Haemarthrosis 118 14.6% 5 26
Haemorrhage 112 13.8% 5 37
Drug ineffective 69 8.5% 5 14
No adverse event 64 7.9% 1 10
Epistaxis 43 5.3% 1 11
Acquired haemophilia 41 5.1% 41 14
Arthralgia 40 4.9% 2 12
Fall 37 4.6% 1 18
Device issue 36 4.5% 1 1
Pre-existing disease 36 4.5% 36 13
Therapy partial responder 36 4.5% 35 13
Pain 34 4.2% 1 11
Product preparation issue 34 4.2% 1 1
Drug ineffective for unapproved indication 27 3.3% 2 6
Contusion 25 3.1% 0 13
Factor viii inhibition 25 3.1% 0 3
Death 24 3.0% 24 8
Limb injury 24 3.0% 1 7
Malaise 24 3.0% 1 7
Muscle haemorrhage 24 3.0% 1 9

Who Reports ANTIHEMOPHILIC FACTOR HUMAN Side Effects? Age & Gender Data

Gender: 43.0% female, 57.0% male. Average age: 37.9 years. Most reports from: US. View detailed demographics →

Is ANTIHEMOPHILIC FACTOR HUMAN Getting Safer? Reports by Year

YearReportsDeathsHosp.
2000 1 0 0
2001 2 0 0
2002 1 0 1
2006 1 0 0
2007 1 0 0
2009 4 0 0
2010 11 0 5
2011 1 0 0
2012 1 0 0
2013 3 0 3
2014 4 0 1
2015 17 2 6
2016 28 3 11
2017 42 1 10
2018 44 4 19
2019 81 1 19
2020 60 5 14
2021 26 4 10
2022 22 5 7
2023 26 2 9
2024 15 1 4
2025 14 1 8

View full timeline →

What Is ANTIHEMOPHILIC FACTOR HUMAN Used For?

IndicationReports
Von willebrand's disease 228
Product used for unknown indication 187
Factor viii deficiency 161
Prophylaxis 68
Haemorrhage 44
Haemophilia 34
Acquired haemophilia 33
Immune tolerance induction 18
Gastrointestinal haemorrhage 10
Coagulopathy 9

ANTIHEMOPHILIC FACTOR HUMAN vs Alternatives: Which Is Safer?

ANTIHEMOPHILIC FACTOR HUMAN vs ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT ANTIHEMOPHILIC FACTOR HUMAN vs ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT RESIDUES 743-1636 DELETED ANTIHEMOPHILIC FACTOR HUMAN vs ANTIHEMOPHILIC FACTOR, PEGYLATED HUMAN SEQUENCE RECOMBINANT ANTIHEMOPHILIC FACTOR HUMAN vs ANTIHEMOPHILIC FACTOR PORCINE, B-DOMAIN TRUNCATED RECOMBINANT ANTIHEMOPHILIC FACTOR HUMAN vs APALUTAMIDE ANTIHEMOPHILIC FACTOR HUMAN vs APATINIB ANTIHEMOPHILIC FACTOR HUMAN vs APIDRA ANTIHEMOPHILIC FACTOR HUMAN vs APIDRA SOLOSTAR ANTIHEMOPHILIC FACTOR HUMAN vs APIXABAN ANTIHEMOPHILIC FACTOR HUMAN vs APOMORPHINE

Official FDA Label for ANTIHEMOPHILIC FACTOR HUMAN

Official prescribing information from the FDA-approved drug label.